Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 724

Sort by

Sort Order Select

Journal Articles

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study

Blood Adv (2025) 9 (16): 4126–4135.

https://doi.org/10.1182/bloodadvances.2025016158

Published: 2025

Includes: Supplemental data

Journal Articles

Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome

Sarah Andersen, Glen Kennedy, Merrilyn Banks, Bernadine Flanagan, Andrea Henden

Blood Adv (2025) 9 (16): 4167–4179.

https://doi.org/10.1182/bloodadvances.2024015703

Published: 2025

Includes: Supplemental data

Journal Articles

Frontline allo-SCT in MRD-negative, intermediate-risk AML

Eduardo Rodríguez-Arbolí, Teresa Caballero-Velázquez, Cristina Marrero-Cepeda, José Antonio Pérez-Simón

Blood Adv (2025) 9 (15): 4063–4064.

https://doi.org/10.1182/bloodadvances.2025016610

Published: 2025

Journal Articles

Interpretation of response in BOS: the definitions remain key

Kirsten M. Williams, Vibha Lama, Kenneth R. Cooke, Gregory A. Yanik

Blood Adv (2025) 9 (15): 4058–4060.

https://doi.org/10.1182/bloodadvances.2025015948

Published: 2025

Journal Articles

Targeting PD-1 for HCT relapse: an immunologic knife’s edge

Roman M. Shapiro, Robert J. Soiffer

Blood Adv (2025) 9 (15): 3907–3908.

https://doi.org/10.1182/bloodadvances.2025016709

Published: 2025

Journal Articles

Comparative Outcomes of HCT with Post-Transplant Cyclophosphamide in Older Adults: The Impact of Donor Type

Yosra M. Aljawai, Jeremy L. Ramdial, Portia Smallbone, George Liwei Chen, Partow Kebriaei, Oren Pasvolsky, Uday R. Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood Adv bloodadvances.2025016592.

https://doi.org/10.1182/bloodadvances.2025016592

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis

Yosra M. Aljawai, Jeremy Ramdial, Gabriela Rondon, Portia Smallbone, Partow Kebriaei, Uday Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood Adv (2025) 9 (15): 4023–4036.

https://doi.org/10.1182/bloodadvances.2025016236

Published: 2025

Includes: Supplemental data

Journal Articles

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers.

Teresa Caballero-Velázquez, Javier Delgado-Serrano, Lucia López-Corral, Christelle Ferrá i Coll, Clara Beatriz García-Calderón, David Valcárcel, Irene García Cadenas, Estefanía Pérez López, Maria-Jose Jimenez, Francisco Manuel Martín-Domínguez, María de los Reyes Jiménez-Leon, Guillermo Orti, Virginia Escamilla Gómez, Cristina Blázquez-Goñi, Almudena Cabero Martínez, Henry Antonio Andrade Ruiz, Estefanía Menéndez-Pedregal, Fermín M Sánchez-Guijo, Jose Antonio Pérez-Simón

Blood Adv bloodadvances.2025016284.

https://doi.org/10.1182/bloodadvances.2025016284

Published: 2025

Includes: Supplemental data

Journal Articles

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome

John M. Magenau, David G. Frame, Mary Riwes, John Maciejewski, Sarah Anand, Attaphol Pawarode, Anamarija M. Perry, Marcus Geer, Thomas Braun, Monalisa Ghosh, Pavan Reddy

Blood Adv (2025) 9 (15): 3878–3886.

https://doi.org/10.1182/bloodadvances.2024015200

Published: 2025

Includes: Supplemental data

Journal Articles

To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients

Akshay Sharma, Tami John

Blood Adv (2025) 9 (15): 3845–3852.

https://doi.org/10.1182/bloodadvances.2024015413

Published: 2025

Journal Articles

In search of the perfect donor: youth must be served

Richard J. Jones

Blood Adv (2025) 9 (14): 3540–3542.

https://doi.org/10.1182/bloodadvances.2025016207

Published: 2025

Journal Articles

A Simple and Efficient Method for the Robust Expansion of Human ILC2s to Prevent Acute GvHD

Danny W Bruce, Sonia J Laurie, Yan Xing, Heather E Stefanski, Keli L. Hippen, Alec Wilkinson, Mark G. Woodcock, James Coghill, Karen Peterson McKinnon, Bruce R. Blazar, Jonathan Serody

Blood Adv bloodadvances.2024013609.

https://doi.org/10.1182/bloodadvances.2024013609

Published: 2025

Includes: Supplemental data

Journal Articles

Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

Xavier Poire, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Johan A. Maertens, Nicolaus Kröger, Caroline Besley, Stephanie Nguyen, Cristina Castilla-Llorente, Gérard Socié, Edouard Forcade, Anne Huynh, Igor Wolfgang Blau, Arnon Nagler, Jaime Sanz, Simona Piemontese, Mohamad Mohty, Fabio Ciceri

Blood Adv bloodadvances.2024015582.

https://doi.org/10.1182/bloodadvances.2024015582

Published: 2025

Journal Articles

BMP-2 generates a functional bone marrow niche by inducing the differentiation of local mesenchymal cells into CAR cells

Ikue Tosa, Mitsuaki Ono, Anh Tuan Dang, Ziyi Wang, Maiko Kimura, Wakana Kitagawa, Kei Ishibashi, Hang Thuy Do, Kun Zhao, Emilio Satoshi Hara, Noboru Asada, Takashi Nagasawa, Toshitaka Oohashi, Naoya Ohara, Takuo Kuboki

Blood Adv (2025) 9 (14): 3598–3612.

https://doi.org/10.1182/bloodadvances.2024014062

Published: 2025

Includes: Supplemental data

Journal Articles

Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis

Blood Adv (2025) 9 (14): 3469–3478.

https://doi.org/10.1182/bloodadvances.2024014858

Published: 2025

Includes: Supplemental data

Journal Articles

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

Blood Adv (2025) 9 (14): 3395–3407.

https://doi.org/10.1182/bloodadvances.2024015335

Published: 2025

Includes: Supplemental data

Journal Articles

Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults

Miguel-Angel Perales, Marcie Riches, Naya He, Michael J. Martens, Roy F. Chemaly, Christopher E. Dandoy, Joshua A. Hill, Miguel Angel Diaz, Shahrukh Hashmi, Susan Prockop, Hillard M. Lazarus, Amer M. Beitinjaneh, Gerhard C. Hildebrandt, Jeffery J. Auletta, Paul Szabolcs

Blood Adv (2025) 9 (14): 3502–3517.

https://doi.org/10.1182/bloodadvances.2024015288

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703

Blood Adv (2025) 9 (14): 3495–3501.

https://doi.org/10.1182/bloodadvances.2025015964

Published: 2025

Includes: Supplemental data

Journal Articles

Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study

Blood Adv (2025) 9 (14): 3479–3494.

https://doi.org/10.1182/bloodadvances.2025016170

Published: 2025

Includes: Supplemental data

Journal Articles

Antibiotic use: impact on the microbiome and cellular therapy outcomes

Alicia Darwin, Jiayi Xie, Melody Smith

Blood Adv (2025) 9 (13): 3356–3367.

https://doi.org/10.1182/bloodadvances.2024013809

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study

Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome

Frontline allo-SCT in MRD-negative, intermediate-risk AML

Interpretation of response in BOS: the definitions remain key

Targeting PD-1 for HCT relapse: an immunologic knife’s edge

Comparative Outcomes of HCT with Post-Transplant Cyclophosphamide in Older Adults: The Impact of Donor Type

Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers.

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome

To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients

In search of the perfect donor: youth must be served

A Simple and Efficient Method for the Robust Expansion of Human ILC2s to Prevent Acute GvHD

Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia

BMP-2 generates a functional bone marrow niche by inducing the differentiation of local mesenchymal cells into CAR cells

Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults

Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703

Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study

Antibiotic use: impact on the microbiome and cellular therapy outcomes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only